Assistant Managing Editor The annual abstract release ahead of the American Society of Clinical Oncology (ASCO) meeting – an event simultaneously heralded and dreaded by Wall Street analysts – landed quietly this year, signaling few surprises ahead of Chicago

Not only has rindopepimut shown promising effects in GBM – interim Phase IIb data presented at last year's American Society of Clinical Oncology meeting showed a 70 percent progression-free survival rate at 5.5 months when combined with temozolomide – but a recent analysis by Deloitte Recap showed that losing one partner does not necessarily dissuade interest from others

Science Editor It was a late night for analysts yesterday, as the American Society of Clinical Oncology (ASCO) released more than 4,000 abstracts in advance of its upcoming annual meeting at 6 pm

In January ACT reported at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancer Symposium, in San Francisco, new data from its Phase II trial of telatinib that the company said supported the ability to continuously dose telatinib in patients with stomach cancer combined with full-dose, standard-of-care chemotherapy

During last year's American Society of Clinical Oncology meeting, Plexxikon reported positive early data in colorectal cancer

The American Society of Clinical Oncology sent out multiple e-mail blasts to its members telling them about the availability of Fusilev for colorectal cancer patients

Immune system therapies for cancer have attracted increasing interest since last year's annual meeting of the American Society of Clinical Oncology (ASCO), where clinical studies showing efficacy of such treatments made a big splash. (See BioWorld Today, June 8, 2010.) At the conference, Bristol-Myers Squibb Co

Those are the formal presentation of the interim data from the Atu027 Phase I at next month's American Society of Clinical Oncology meeting and filing for a U.S

Results will be presented at the annual meeting of the American Society of Clinical Oncology, June 3-7

Shukui Qin, who will be the lead investigator in the China portion of the Phase III trial and is president of the Chinese Society of Clinical Oncology and chair of the Chinese Liver Cancer Study Group, said that approximately half of the 700,000 annual liver cancer-related deaths in the world are in China

Data from the pivotal trial dubbed 020, as reported at last year's American Society of Clinical Oncology meeting and published in The New England Journal of Medicine, were solid

At the 2009 American Society of Clinical Oncology meeting, data showed a 100 percent response rate for SCLC patients treated with six cycles of therapy, with progression-free survival data besting historical controls by about 50 percent

Full data are expected at this year's American Society of Clinical Oncology meeting

At the 2009 American Society of Clinical Oncology meeting, data showed a 100 percent response rate for SCLC patients treated with six cycles of therapy, with progression-free survival data besting historical controls by about 50 percent

The anemia issue "has been a focal point of recent controversy," J.P. Morgan's Cory Kasimov said in a March 15 note, "but one that we suspect investors will gain greater comfort with" at the June meeting of the American Society of Clinical Oncology (ASCO

Allon Therapeutics Inc., of Vancouver, British Columbia, presented clinical trial results confirming the positive pharmacokinetic characteristics of the company's lead neuroprotective drug candidate, davunetide, at the American Society for Clinical Pharmacology and Therapeutics annual meeting in Dallas

Genomic Health Inc., of Redwood City, Calif., presented two studies at the American Society of Clinical Oncology Genitourinary Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple tumor samples examined in each patient

Data were presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco

Those data were presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco